The DOI matches its Crossref record; 258 of the 258 references it cites were found in a registry or an index.
The cannabinoid system and pain
Open accessAbstract
Abstract Chronic pain states are highly prevalent and yet poorly controlled by currently available analgesics, representing an enormous clinical, societal, and economic burden. Existing pain medications have significant limitations and adverse effects including tolerance, dependence, gastrointestinal dysfunction, cognitive impairment, and a narrow therapeutic window, making the search for novel analgesics ever more important. In this article, we review the role of an important endogenous pain control system, the endocannabinoid (EC) system, in the sensory, emotional, and cognitive aspects of pain. Herein, we briefly cover the discovery of the EC system and its role in pain processing pathways, before concentrating on three areas of current major interest in EC pain research; 1. Pharmacological enhancement of endocannabinoid activity (via blockade of EC metabolism or allosteric modulation of CB1 receptors); 2. The EC System and stress‐induced modulation of pain; and 3. The EC system & medial prefrontal cortex (mPFC) dysfunction in pain states. Whilst we focus predominantly on the preclinical data, we also include extensive discussion of recent clinical failures of endocannabinoid‐related therapies, the future potential of these approaches, and important directions for future research on the EC system and pain. This article is part of the Special Issue entitled “A New Dawn in Cannabinoid Neurobiology”. HighlightsThe endocannabinoid (EC) system is a key endogenous pain control system.Elevating or enhancing EC signalling is antinociceptive in preclinical models.Recent clinical failures suggest study limitations and gaps in basic knowledge.Future directions and strategies to improve clinical translation are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–258 of 258
Karbarz, M. J., Luo, L., Chang, L., Tham, C.-S., Palmer, J. A., Wilson, S. J., Wennerholm, M. L., Brown, S. M., Scott, B. P., Apodaca, R. L., et al. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31818c7cbd · Cited by 74
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model
Barnes, N. S. A., Mitchell, V. A., Kazantzis, N. P., & Vaughan, C. W. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13337 · Cited by 73
Endocannabinoids in Neuroimmunology and Stress
Carrier, E. J., Patel, S., & Hillard, C. J. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/156800705774933023 · Cited by 72
Neuroinflammatory Mechanisms Linking Pain and Depression
Burke, N. N., Finn, D. P., & Roche, M. (2015) · Modern trends in psychiatry · doi:10.1159/000435931 · Cited by 72
Self-citationInhibition of Anandamide Hydrolysis by the Enantiomers of Ibuprofen, Ketorolac, and Flurbiprofen
Fowler, C. J., Janson, U., Johnson, R. M., Wahlström, G., Stenström, A., Norström, Å., & Tiger, G. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.1025 · Cited by 71
Strain difference in the effect of infralimbic cortex lesions on fear extinction in rats.
Chang, C., & Maren, S. (2010) · Behavioral Neuroscience · doi:10.1037/a0019479 · Cited by 69
Fear Extinction Induces mGluR5-Mediated Synaptic and Intrinsic Plasticity in Infralimbic Neurons
Sepulveda-Orengo, M. T., López, A. V., Soler‐Cedeño, O., & Porter, J. T. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5198-12.2013 · Cited by 69
Niphakis, M. J., Johnson, D. S., Ballard, T. E., Stiff, C. M., & Cravatt, B. F. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200089j · Cited by 69
Wilkerson, J. L., Niphakis, M. J., Grim, T. W., Mustafa, M. A., Abdullah, R. A., Poklis, J. L., Dewey, W. L., Akbarali, H. I., Banks, M. L., Wise, L. E., et al. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.229971 · Cited by 69
Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive
Sasso, O., Wagner, K., Morisseau, C., Inceoglu, B., Hammock, B. D., & Piomelli, D. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.04.001 · Cited by 68
Kaczocha, M., Glaser, S. T., Maher, T., Clavin, B., Hamilton, J., Rourke, J. O., Rebecchi, M., Puopolo, M., Owada, Y., & Thanos, P. K. (2015) · Molecular Pain · doi:10.1186/s12990-015-0056-8 · Cited by 68
Stereochemistry of the π-route to 2,4-disubstituted adamantanes
Sasaki, T., Eguchi, S., & Toru, T. (1971) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)96639-0 · Cited by 67
Hegyi, Z., Kis, G. N., Holló, K., Ledent, C. A., & Antal, M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06816.x · Cited by 67
Finn, D. P., Beckett, S. R. G., Richardson, D., Kendall, D. A., Marsden, C. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03509.x · Cited by 66
Self-citationWoodhams, S. G., Wong, A., Barrett, D. A., Bennett, A. J., Chapman, V., & Alexander, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02179.x · Cited by 66
Self-citationOkine, B. N., Norris, L. M., Woodhams, S. G., Burston, J. J., Patel, A., Alexander, S. P. H., Barrett, D. A., Kendall, D. A., Bennett, A. J., & Chapman, V. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02028.x · Cited by 65
Self-citationCosta, B., Bettoni, I., Petrosino, S., Comelli, F., Giagnoni, G., & Di Marzo, V. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.02.001 · Cited by 64 · cited 2×
“AA-5-HT has antinociceptive efficacy in the formalin and carrageenan models of inflammation, and the CCI and SNI models of neuropathic pain (Costa et al., 2010; de Novellis et al., 2008; de Novellis et al., 2011; Maione et al., 2007; Malek et al., 2016), whilst OMDM-198 is effective in the formalin and carrageenanmode…”
Malek, N., Mrugala, M., Makuch, W., Kolosowska, N., Przewlocka, B., Binkowski, M., Czaja, M., Morera, E., Di Marzo, V., & Starowicz, K. (2015) · Pain · doi:10.1097/j.pain.0000000000000132 · Cited by 63 · cited 2×
“…pain (Costa et al., 2010; de Novellis et al., 2008; de Novellis et al., 2011; Maione et al., 2007; Malek et al., 2016), whilst OMDM-198 is effective in the formalin and carrageenanmodels of inflammatory pain (Maione et al., 2013), and a rat model of osteoarthritic pain (Malek et al., 2015).”
Sasso, O., Migliore, M., Habrant, D., Armirotti, A., Albani, C., Summa, M., Moreno‐Sanz, G., Scarpelli, R., & Piomelli, D. (2015) · The FASEB Journal · doi:10.1096/fj.15-270637 · Cited by 63
Neuropeptide S: a novel regulator of pain-related amygdala plasticity and behaviors
Ren, W., Kiritoshi, T., Grégoire, S., Ji, G., Guerrini, R., Calò, G., & Neugebauer, V. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00874.2012 · Cited by 63
Self-citationHigh Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity
Fitzgibbon, M., Finn, D. P., & Roche, M. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv095 · Cited by 63
Self-citationGuindon, J., LoVerme, J., Léan, A. D., Piomelli, D., & Beaulieu, P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.045 · Cited by 60
Pawsey, S., Wood, M., Browne, H. L., Donaldson, K. M., Christie, M. I., & Warrington, S. (2016) · Drugs in R&D · doi:10.1007/s40268-016-0127-y · Cited by 58
Fowler, C., Naidu, P., Lichtman, A. H., & Onnis, V. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00029.x · Cited by 57
Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1
Kiritoshi, T., Sun, H., Ren, W., Stauffer, S. R., Lindsley, C. W., Conn, P. J., & Neugebauer, V. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.03.024 · Cited by 55
Self-citationIncreased thermal and mechanical nociceptive thresholds in rats with depressive-like behaviors
Shi, M., Qi, W., Gao, G., Wang, J., & Luo, F. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.023 · Cited by 55
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
Gamble-George, J. C., Baldi, R., Halladay, L., Kocharian, A., Hartley, N., Silva, C. G., Roberts, H., Haymer, A., Marnett, L. J., Holmes, A., et al. (2016) · eLife · doi:10.7554/elife.14137 · Cited by 55
A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase
Carey, L. M., Slivicki, R. A., Leishman, E., Cornett, B., Mackie, K., Bradshaw, H. B., & Hohmann, A. G. (2016) · Molecular Pain · doi:10.1177/1744806916649192 · Cited by 55
Self-citationGhosh, S., Kinsey, S. G., Liu, Q.-S., Hruba, L., McMahon, L. R., Grim, T. W., Merritt, C. R., Wise, L. E., Abdullah, R. A., Selley, D. E., et al. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.222851 · Cited by 54 · cited 11×
“URB597 significantly reduced the widespread hyperalgesia induced via combined CUS and NGF in this study, while JZL184 had no significant effect (Lomazzo et al., 2015).”
InfluentialDesroches, J., Charron, S., Bouchard, J., & Beaulieu, P. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.006 · Cited by 54
Grim, T. W., Ghosh, S., Hsu, K.-L., Cravatt, B. F., Kinsey, S. G., & Lichtman, A. H. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.07.008 · Cited by 50
Wędzony, K., & Chocyk, A. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70161-6 · Cited by 50
de Novellis, V., Palazzo, E., Rossi, F., PETROCELLIS, L. D., Petrosino, S., Guida, F., Luongo, L., Migliozzi, A., Cristino, L., Marabese, I., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.023 · Cited by 50
Rea, K., Olango, W. M., Harhen, B., Kerr, D. M., Galligan, R., Fitzgerald, S. T., Moore, M., Roche, M., & Finn, D. P. (2012) · Pain · doi:10.1016/j.pain.2012.12.021 · Cited by 46
Self-citationIndividual Differences in the Emotional Reaction to Shock Determine Whether Hypoalgesia Is Observed
Rhudy, J. L., & Meagher, M. W. (2003) · Pain Medicine · doi:10.1046/j.1526-4637.2003.03028.x · Cited by 45
The Role of the Endogenous Cannabinoid System in Peripheral Analgesia
Guindon, J., & Beaulieu, P. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902010134 · Cited by 45
Starowicz, K., & Marzo, V. D. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.075 · Cited by 43
Sensory decision theory analysis of the effects of anxiety and experimental instructions on pain.
Dougher, M. J. (1979) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.88.2.137 · Cited by 40
Ford, G. K., Kieran, S., Dolan, K., Harhen, B., & Finn, D. P. (2011) · Pain · doi:10.1016/j.pain.2011.07.014 · Cited by 37
Self-citationMaione, S., Costa, B., Piscitelli, F., Morera, E., Chiaro, M. D., Comelli, F., Boccella, S., Guida, F., Verde, R., Ortar, G., et al. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.07.003 · Cited by 36
Rivera, P., Arrabal, S., Cifuentes, M., Grondona, J. M., Pérez‐Martín, M., Rubio, L., Vargas, A., Serrano, A., Pavón, F. J., Suárez, J., et al. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00056 · Cited by 35
Jennings, E. M., Okine, B. N., Olango, W. M., Roche, M., & Finn, D. P. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.05.008 · Cited by 33
Self-citationNavia‐Paldanius, D., Aaltonen, N., Lehtonen, M., Savinainen, J. R., Taschler, U., Radner, F. P. W., Zimmermann, R., & Laitinen, J. T. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.06.005 · Cited by 33
Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain
Sagar, D. R., Jhaveri, M. D., Richardson, D. S., Gray, R., de Lago, E., Fernández‐Ruíz, J., Barrett, D. A., Kendall, D. A., & Chapman, V. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07162.x · Cited by 33
Self-citationSuplita, R. L., Eisenstein, S. A., Neely, M. H., Moise, A. M., & Hohmann, A. G. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.006 · Cited by 33
Self-citationRoche, M., Johnston, P., Mhuircheartaigh, O. N., Olango, W. M., Mackie, K., & Finn, D. P. (2009) · European Journal of Pain · doi:10.1016/j.ejpain.2009.08.009 · Cited by 33
Self-citationMarek, G. J., & Zhang, C. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.083 · Cited by 31
Lessons from the fatal French study BIA-10-2474
Moore, N. D. (2016) · BMJ · doi:10.1136/bmj.i2727 · Cited by 30
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain
Małek, N., Kostrzewa, M., Makuch, W., Pajak, A., Kucharczyk, M. W., Piscitelli, F., Przewłocka, B., Marzo, V. D., & Starowicz, K. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.012 · Cited by 30
Seidel, K., Hamza, M., Ateş, M., & Gühring, H. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01366-6 · Cited by 28
Kurrikoff, K., Inno, J., Matsui, T., & Vasar, E. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06160.x · Cited by 27
Shen, L., Yang, X., Qian, W., & Hou, X. (2010) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2010.16.3.281 · Cited by 26
Genotype-dependent responsivity to inflammatory pain: A role for TRPV1 in the periaqueductal grey
Madasu, M. K., Okine, B. N., Olango, W. M., Rea, K., Lenihan, R., Roche, M., & Finn, D. P. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.011 · Cited by 20
Self-citationHorváth, E., Woodhams, S. G., Nyilas, R., Henstridge, C. M., Kano, M., Sakimura, K., Watanabe, M., & Katona, I. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12470 · Cited by 18
Self-citationSetbacks in the Clinical Development of TRPV1 Antagonists: What Next?
Gavva, N. R. (2009) · The Open Drug Discovery Journal · doi:10.2174/1877381800901010001 · Cited by 17
Okine, B. N., Gaspar, J. C., Madasu, M. K., Olango, W. M., Harhen, B., Roche, M., & Finn, D. P. (2016) · Brain Research · doi:10.1016/j.brainres.2016.11.022 · Cited by 9
Self-citationA FAAH-fetched approach to treat osteoarthritis pain
Lichtman, A. H., & Chapman, V. (2011) · Pain · doi:10.1016/j.pain.2011.02.034 · Cited by 5
Self-citationSpinal cannabinoids – a double‐edged sword? (Commentary on Zhang et al.)
Zeilhofer, H. U. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07125.x · Cited by 5
Cited by
Cannabinoid Ligands Targeting TRP Channels
Muller, C., Morales, P., & Reggio, P. H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00487 · Cited by 567
Cannabinoids and Pain: New Insights From Old Molecules
Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 376
A neuronal circuit for activating descending modulation of neuropathic pain
Huang, J., Gadotti, V. M., Chen, L., Souza, I. A., Huang, S., Wang, D., Ramakrishnan, C., Deisseroth, K., Zhang, Z., & Zamponi, G. W. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0481-5 · Cited by 329
Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
Finn, D. P., Haroutounian, S., Hohmann, A. G., Krane, E., Soliman, N., & Rice, A. S. C. (2021) · Pain · doi:10.1097/j.pain.0000000000002268 · Cited by 254
Self-citationGoods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
Metadata
- Authors
- Woodhams, S. G., Chapman, V., Finn, D. P., Hohmann, A. G., & Neugebauer, V.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 124
- Pages
- 105-120
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2626577148
- Cited by
- 267
- References
- 258
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.